WO2004071394A3 - Agents de diagnostic et de traitement destines aux maladies associees a hm74 (hm74) - Google Patents
Agents de diagnostic et de traitement destines aux maladies associees a hm74 (hm74) Download PDFInfo
- Publication number
- WO2004071394A3 WO2004071394A3 PCT/EP2004/000885 EP2004000885W WO2004071394A3 WO 2004071394 A3 WO2004071394 A3 WO 2004071394A3 EP 2004000885 W EP2004000885 W EP 2004000885W WO 2004071394 A3 WO2004071394 A3 WO 2004071394A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- diseases
- therapeutics
- diagnostics
- compounds
- diseases associated
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
- G01N33/57488—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds identifable in body fluids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones
- G01N2333/726—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Cell Biology (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- General Physics & Mathematics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Endocrinology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP04707151A EP1597586A2 (fr) | 2003-02-13 | 2004-01-31 | Agents de diagnostic et de traitement destines aux maladies associees a hm74 (hm74) |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP03003115 | 2003-02-13 | ||
EP03003115.7 | 2003-02-13 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2004071394A2 WO2004071394A2 (fr) | 2004-08-26 |
WO2004071394A3 true WO2004071394A3 (fr) | 2005-01-20 |
Family
ID=32864931
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2004/000885 WO2004071394A2 (fr) | 2003-02-13 | 2004-01-31 | Agents de diagnostic et de traitement destines aux maladies associees a hm74 (hm74) |
Country Status (2)
Country | Link |
---|---|
EP (1) | EP1597586A2 (fr) |
WO (1) | WO2004071394A2 (fr) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004083388A2 (fr) | 2003-03-14 | 2004-09-30 | Bristol-Myers Squibb Company | Polynucleotide codant un nouveau variant de recepteur de hm74, hgprbmy74 couple a une proteine g humaine |
EP1819684B1 (fr) | 2004-12-03 | 2013-08-07 | Intervet International B.V. | Piperazines substituees en tant qu'antagonistes de cb1 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998056820A1 (fr) * | 1997-06-12 | 1998-12-17 | Smithkline Beecham Corporation | Recepteur hm74a |
WO2001073029A2 (fr) * | 2000-03-27 | 2001-10-04 | Pe Corporation (Ny) | Recepteurs couples aux proteines g humaines isolees, molecules d'acides nucleiques codant les proteines gpcr humaines, et utilisations correspondantes |
WO2001077320A2 (fr) * | 2000-04-05 | 2001-10-18 | Bayer Aktiengesellschaft | Regulation du recepteur couple aux proteines g humain du type hm74 |
WO2001094385A2 (fr) * | 2000-06-05 | 2001-12-13 | Bayer Aktiengesellschaft | Regulation du recepteur couple a la proteine humaine g de type hm74 |
WO2002061087A2 (fr) * | 2000-12-19 | 2002-08-08 | Lifespan Biosciences, Inc. | Peptides antigeniques destines a des recepteurs couples a la proteine g (gpcr), anticorps s'y rapportant, et systeme d'identification desdits peptides antigeniques |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0021484D0 (en) * | 2000-09-01 | 2000-10-18 | Boehringer Ingelheim Pharma | Method for identifying substances which positively influence inflammatory conditions of chronic inflammatory airway diseases |
-
2004
- 2004-01-31 EP EP04707151A patent/EP1597586A2/fr not_active Withdrawn
- 2004-01-31 WO PCT/EP2004/000885 patent/WO2004071394A2/fr active Application Filing
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998056820A1 (fr) * | 1997-06-12 | 1998-12-17 | Smithkline Beecham Corporation | Recepteur hm74a |
WO2001073029A2 (fr) * | 2000-03-27 | 2001-10-04 | Pe Corporation (Ny) | Recepteurs couples aux proteines g humaines isolees, molecules d'acides nucleiques codant les proteines gpcr humaines, et utilisations correspondantes |
WO2001077320A2 (fr) * | 2000-04-05 | 2001-10-18 | Bayer Aktiengesellschaft | Regulation du recepteur couple aux proteines g humain du type hm74 |
WO2001094385A2 (fr) * | 2000-06-05 | 2001-12-13 | Bayer Aktiengesellschaft | Regulation du recepteur couple a la proteine humaine g de type hm74 |
WO2002061087A2 (fr) * | 2000-12-19 | 2002-08-08 | Lifespan Biosciences, Inc. | Peptides antigeniques destines a des recepteurs couples a la proteine g (gpcr), anticorps s'y rapportant, et systeme d'identification desdits peptides antigeniques |
Non-Patent Citations (1)
Title |
---|
See also references of EP1597586A2 * |
Also Published As
Publication number | Publication date |
---|---|
WO2004071394A2 (fr) | 2004-08-26 |
EP1597586A2 (fr) | 2005-11-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2005093092A3 (fr) | Diagnostic et traitement de maladies associees au recepteur 44 couple aux proteines g (gpr44) | |
WO2005106491A3 (fr) | Diagnostic et traitement therapeutique de maladies associees a la kinase 1 regulee par serum/glucocorticoide (sgk1) | |
WO2004042389A3 (fr) | Moyens diagnostiques et therapeutiques destines a des maladies associees a la phosphodiesterase 4d (pde4d) humaine | |
WO2003093816A3 (fr) | Diagnostics et therapeutiques pour lutter contre des maladies associees au recepteur de l'oxytocine (oxtr) | |
WO2004042402A3 (fr) | Moyens diagnostiques et therapeutiques destines a des maladies associees au mrgx1 humain | |
WO2004071378A3 (fr) | Methodes diagnostiques et therapeutiques relatives a des etats pathologiques lies au recepteur hm74a couple a la proteine g | |
WO2004071394A3 (fr) | Agents de diagnostic et de traitement destines aux maladies associees a hm74 (hm74) | |
WO2003065044A3 (fr) | Agents diagnostiques et therapeutiques destines a des maladies associees a gpr72 | |
WO2004038405A3 (fr) | Diagnostics et therapeutiques pour maladies liees au recepteur 43 couple a la proteine g (gpr43) | |
WO2005031345A3 (fr) | Diagnostic et therapeutique de maladies associees au recepteur couple a la proteine g adipor2 (adipor2) | |
WO2005101011A3 (fr) | Agents diagnostiques therapeutiques pour des maladies associees a lxr-alpha (lxra) | |
WO2005075983A3 (fr) | Agents diagnostiques et therapeutiques destines a des maladies associees a un recepteur nucleaire humain nr4a3 (nr4a3) | |
WO2004038421A3 (fr) | Agents diagnostiques et therapeutiques pour maladies associees au recepteur 41 couple a une proteine g humaine (gpr41) | |
WO2003066077A3 (fr) | Outil de diagnostic et therapeutique pour des maladies associees au recepteur de neuromedine u1 (nmu1) | |
WO2004080374A3 (fr) | Diagnostics et therapies pour maladies associees a la phosphodi-esterase 1c (pde1c) | |
WO2005040791A3 (fr) | Diagnostics et therapeutiques pour maladies liees au recepteur de peptides similaire a la somatostatine et a l'angiogenine (salpr) | |
WO2003100433A3 (fr) | Diagnostics et therapies pour maladies liees au recepteur 3 de l'arginine vasopressine (avpr3) | |
WO2004042076A3 (fr) | Diagnostic et therapeutique de maladies associees a la phosphodiesterase 4a (pde4a) humaine | |
WO2004042405A3 (fr) | Diagnostic et therapeutique pour maladies associees au recepteur 3 couples aux proteines g (gpr3) humain | |
WO2003100435A3 (fr) | Procede pour diagnostiquer et traiter des maladies associees au recepteur de neuromedine u2 (nmu2) | |
WO2006013015A3 (fr) | Diagnostics et therapeutique pour maladies liees a la marapsine (mpn) | |
WO2005075990A3 (fr) | Diagnostics et therapeutiques pour maladies associees au recepteur nucleaire humain nr4a2 (nr4a2) | |
WO2004038406A3 (fr) | Diagnostic et therapie de maladies associees au recepteur 42 couple a la proteine g (gpr42) humain | |
WO2006013012A3 (fr) | Diagnostics et therapeutique pour maladies liees a la napsine 1 (nap1) | |
WO2005040792A3 (fr) | Diagnostics et therapeutiques pour des maladies associees a l'arginyl aminopeptidase (aminopeptidase b)-de type 1 (rnpepl1) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2004707151 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2004707151 Country of ref document: EP |